New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 2, 2014
06:22 EDTCTSHCognizant upgraded to Buy from Neutral at UBS
UBS upgraded Cognizant and said it is well positioned for the current demand environment as IT budgets are focused on cost optimization and believes discretionary project spending will be solid. The analyst expect Cognizant to announce a more formal capital return policy this year and views valuation as attractive. Price target raised to $58 from $50.
News For CTSH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 6, 2015
10:01 EDTCTSHOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: 58.com (WUBA) upgraded to Buy from Hold at Summit Research... Altria Group (MO) upgraded to Buy from Outperform at CLSA... Ares Commercial (ACRE) upgraded to Outperform from Market Perform at FBR Capital... BAE Systems (BAESY) upgraded to Overweight from Equal Weight at Morgan Stanley... BGC Partners (BGCP) upgraded to Strong Buy from Outperform at Raymond James... Cognizant (CTSH) upgraded to Buy on valuation at CLSA... Edwards Lifesciences (EW) upgraded to Overweight from Equal Weight at Morgan Stanley... Guess (GES) upgraded to Neutral from Underweight at Piper Jaffray... MarkWest Energy (MWE) upgraded to Overweight from Equal Weight at Barclays... Palo Alto (PANW) upgraded to Outperform following checks at Cowen... The Medicines Co. (MDCO) upgraded to Buy from Neutral at Mizuho... TripAdvisor (TRIP) upgraded to Equal Weight from Underweight at Barclays... Union Pacific (UNP) upgraded to Outperform at Cowen... United Continental (UAL) upgraded to Buy from Fair Value at CRT Capital... eHealth (EHTH) upgraded on Medicare outlook, risk/reward at RBC Capital.
08:18 EDTCTSHCognizant upgraded to Buy on valuation at CLSA
As previously reported, CLSA upgraded Cognizant to Buy from Outperform with a $75 price target. The firm would use weakness as a buying opportunity and said the loss of the Health Net (HNT) contract was very sub-par margin revenue.
06:17 EDTCTSH, CTSHCognizant upgraded to Buy from Outperform at CLSA
July 2, 2015
12:00 EDTCTSHCognizant ability to offset Health Net loss a positive, says Wells Fargo
Wells Fargo notes that despite the loss of $100M in revenue in the second half of 2015 from the Health Net (HNT) master services agreement being put on hold during the Centene (CNC) merger review process, Cognizant (CTSH) reaffirmed its outlook today for 2015. Wells views the company's ability to offset the contract loss as a positive and says it remains comfortable with an Outperform rating on the stock.
09:36 EDTCTSHCognizant backs FY15 EPS view of at least $2.93, consensus $2.97
Subscribe for More Information
09:33 EDTCTSHCognizant reaffirms 2015 view after Health Net agrees to be bought by Centene
Subscribe for More Information
June 24, 2015
05:35 EDTCTSHCognizant announces strategic relationship with Escorts Limited
Cognizant announced a strategic relationship with Escorts Limited, one of India's engineering conglomerates, to modernize Escorts' technology landscape and help achieve the company's vision of digitally transforming its businesses to deliver innovative products, provide superior customer experience, and drive growth. This multi-year, multi-million dollar engagement spans all of Escort's businesses, including agri-machinery, material handling and construction equipment, railway equipment and auto components. Cognizant will enable Escorts to improve control and collaboration across its value chain by mobile-enabling its workforce and integrating multiple systems used by vendors, sales partners, and customers. This will help Escorts continuously improve product quality and offer a broad range of customized, configurable, and value-added products and services, strengthening existing customer relationships and building new ones.
June 22, 2015
09:01 EDTCTSHCognizant management to meet with JPMorgan
Meetings to be held in Berwyn/Princeton/Trenton on June 25 hosted by JPMorgan.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use